Organized by:

Technical Secretariat:

Registrations: www.mdanderson.es/pathologymeeting @MDAnderson_ES

Meeting Directors:

Dr. Joseph Khoury Dr. Juan Fernando García

Under the auspices of:

Madrid, April 15-17, 2020

3rd PATHOLOGY MEETINGCANCER-RELATEDB I O M A R K E R S A N DT H E R A P E U T I C I M P L I C A T I O N S

INFL AMMATION

Monasterios de Suso y Yuso 34 · 28049 Madrid (+34) 91 372 02 03 e-mail: pathologymeeting@doctaforum.comwww.mdanderson.es/pathologymeeting

Venue (April 15, 2020):

Ilustre Colegio de Médicos de MadridSanta Isabel, 5128012 Madrid, Spain

Venue (April 16 to 17, 2020):

MD Anderson Foundation Spain AuditoriumArturo Soria, 27028033 Madrid, Spain

Accreditation:

Applications for CME credits will be forwarded to the Spanish Accreditation Council for Continuing Medical Education.

With the collaboration of the Educational Committee of MD Anderson Cancer Center Madrid.

Language:

The official language of the meeting will be English.

Wednesday, April 15, 2020

14:00 - 16:00 Registration & welcome

16:00 - 16:15 Welcome and opening remarks Dr. Joseph Khoury, MD Anderson Cancer Center, Houston, USA Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain Dr. Pedro Luis Cobiella, President, MD Anderson Cancer Center Madrid, Spain

16:15 - 17:15 Keynote lecture: cancer-related in�ammation Dr. James P. Allison, MD Anderson Cancer Center, Houston, USA

17:15 - 19:15 SESSION 1. Genitourinary tumors Moderators: Dr. Enrique Grande, MD Anderson Cancer Center Madrid, Spain Dr. Padmanee Sharma, MD Anderson Cancer Center, Houston, USA

17:15 - 17:55 Bladder cancer. Biology Dr. Francisco X. Real, Spanish National Cancer Center (CNIO)

17:55 - 18:35 Bladder cancer. Immunotherapy Dr. Padmanee Sharma, MD Anderson Cancer Center, Houston, USA

18:35 - 19:15 Prostate cancer Dr. Ana Aparicio, MD Anderson Cancer Center, Houston, USA

19:15 - 19:30 Discussion19:30 - 21:15 Welcome reception

�ursday, April 16, 2020

08:30 - 08:35 Opening remarks

08:35 - 11:25 SESSION 2. Keynote symposium Moderator: : Dr. Joseph Khoury, MD Anderson Cancer Center, Houston, USA

08:35 - 09:15 Immunity, in�ammation and cancer: basics Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain

09:15 - 09:55 Immunocheckpoint drugs. A review for pathologists Dr. Ana Aparicio, MD Anderson Cancer Center, Houston, USA

09:55 - 10:35 Drugs and biomarkers in solid tumors PDL1, regulation and multiplex immunpro�ling Dr. José Luis Solórzano, MD Anderson Cancer Center Madrid, Spain

10:35 - 11:15 Cutaneous complications of immunotherapy Dr. Jonathan Curry, MD Anderson Cancer Center, Houston, USA

11:15 - 11:30 Discussion

11:30 - 11:50 Co�ee Break

11:50 - 13:50 SESSION 3. Lung, head and neck tumors Moderator: Dr. Pilar López-Criado, MD Anderson Cancer Center Madrid, Spain

11:50 - 12:30 Predictive biomarkers for lung cancer immunotherapy Dr. Ignacio Wistuba, MD Anderson Cancer Center, Houston, USA

12:30 - 13:10 TBC Dr. Montserrat Sánchez-Céspedes, Josep Carreras Leukemia Research Institute, Barcelona, Spain

13:10 - 13:50 Rare H&N aggressive neoplasms: salivary gland, NUT Dr. Michelle Williams, MD Anderson Cancer Center, Houston, USA

13:50 - 14:05 Discussion

14:05 - 15:35 Lunch

15:35 - 17:35 SESSION 4. Hematolymphoid tumors Moderator: Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain

15:35 - 16:15 Immunotherapy in B-cell lymphomas and leukemias Dr. Joseph Khoury, MD Anderson Cancer Center, Houston, USA

16:15 - 16:55 CD30 as a diagnostic marker and target of therapy Dr. Roland Schwarting, Cooper University Health Care, New Jersey, USA

16:55 - 17:35 CAR-T technology: present and future Dr. Manel Juan, Hospital Clinic-IDIBAPS, Barcelona, Spain

17:35 - 17:50 Discussion

17:50 - 18:55 SESSION 5. Slide seminar Moderator: TBC

Special seminar: four to six cases focused on immunotherapy/biomarkers, illustrating the role of molecular pathology in clinical decision making processes

Friday, April 17, 2020

08:30 - 10:30 SESSION 6. Central nervous system tumors Moderator: Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain

08:30 - 09:10 Pathology of CNS tumors Dr. Gregory N. Fuller, MD Anderson Cancer Center, Houston, USA

09:10 - 09:50 Molecular pathology Dr. Bárbara Meléndez, Erasme Hospital, Brussels, Belgium

09:50 - 10:30 Microenvironment Dr. Joan Seoane, Hospital Universitari Vall d´Hebron, Barcelona, Spain

10:30 - 10:45 Discussion

10:45 - 11:00 Co�ee Break

11:00 - 13:00 SESSION 7. Skin tumors Moderator: Dr. Victor Prieto, MD Anderson Cancer Center, Houston, USA

11:00 - 11:40 Clinical concepts on immunotherapy in aggressive cutaneous tumors: melanoma & Merkel carcinoma Dr. Pilar López-Criado, MD Anderson Cancer Center Madrid, Spain

11:40 - 12:20 Targeted therapies and immunotherapy in melanoma Dr. Victor Prieto, MD Anderson Cancer Center, Houston, USA

12:20 - 13:00 Update on Merkel carcinoma Dr. Jonathan Curry, MD Anderson Cancer Center, Houston, USA

13:00 - 13:15 Discussion

13:15 - 14:20 SESSION 8. Slide seminar Moderator: Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain

Special seminar: four to six cases focused on immunotherapy/biomarkers, illustrating the role of molecular pathology in clinical decision making processes14:20 - 14:30 Closing remarks Dr. Joseph Khoury, MD Anderson Cancer Center, Houston, USA Dr. Juan F. García, MD Anderson Cancer Center Madrid, Spain

3rd PATHOLOGY MEETINGCANCER-RELATEDB I O M A R K E R S A N DT H E R A P E U T I C I M P L I C A T I O N S

INFL AMMATION